Trials / Completed
CompletedNCT02767960
Serum Tenascin-C Concentration in Patients With Acute Coronary Syndrome
Change of Serum Tenascin-C Concentration and the Relationship With Hs-CRP，cTnI and Prognosis in Patients With Acute Coronary Syndrome
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 183 (actual)
- Sponsor
- The First Affiliated Hospital of Dalian Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study valuates the serum Tenascin-C concentration in patients with acute coronary syndrome.
Detailed description
It is found that Tenascin-C plays an important role in ventricular remodeling, heart failure, aortic dissection, rheumatic heart disease and other cardiovascular diseases, which may be a new marker for the diagnosis and prognosis prediction of these diseases. However, there is few relevant studies about the Tenascin-C concentration in patients with acute coronary syndrome.This study valuates the serum Tenascin-C concentration in patients with acute coronary syndrome.
Conditions
Timeline
- Start date
- 2016-05-01
- Primary completion
- 2017-01-01
- Completion
- 2017-07-01
- First posted
- 2016-05-11
- Last updated
- 2017-08-01
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02767960. Inclusion in this directory is not an endorsement.